BridgeMD
New treatment option for Smoking Cessation
Official title Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients
ClinicalTrials.gov ID: NCT07441928
What this study is testing
- What it's testing
- The prevalence of smoking among people with schizophrenia (SCZ) is substantially higher at 54% to 90% (McClave et al., 2010). About half of all deaths amongst people with scz are attributed to smoking-related diseases and cancer involving the lung, the cardiovascular system, and the liver (Kely et al., 2011; WHO, 2019).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Individuals who have been diagnosed with schizophrenia or schizoaffective disorder and after at least one-year followup;
- currently taking anti-psychotic medications for ≥ 3 months with good compliance;
- aged 18 years or above;
- able to communicate in Cantonese
You likely can't join if
- Have any other current or past psychotic disorders;
- with fleeting or actual suicidal/self-harm ideations, or acting-out behavior in the past;
- with a known history of violence/aggression and a forensic history
- Categorized with special care or intensive care (e.g., arson, battery, physical assault, rape, murder, etc.)
- Have a lifetime history of substance abuse and/or are currently receiving treatment for substance abuse (e.g., opioids, cocaine, marijuana, or...
- With alcohol consumption exceeding 25 standard drinks/week for men and 20 standard drinks/week for women over the last 6 months;
See the full eligibility criteria
- Individuals who have been diagnosed with schizophrenia or schizoaffective disorder and after at least one-year followup;
- currently taking anti-psychotic medications for ≥ 3 months with good compliance;
- aged 18 years or above;
- able to communicate in Cantonese
- Have any other current or past psychotic disorders;
- with fleeting or actual suicidal/self-harm ideations, or acting-out behavior in the past;
- with a known history of violence/aggression and a forensic history
- Categorized with special care or intensive care (e.g., arson, battery, physical assault, rape, murder, etc.)
- Have a lifetime history of substance abuse and/or are currently receiving treatment for substance abuse (e.g., opioids, cocaine, marijuana, or stimulants);
- With alcohol consumption exceeding 25 standard drinks/week for men and 20 standard drinks/week for women over the last 6 months;
- Have received a diagnosis of alcohol or drug dependence in the year preceding recruitment;
- Are pregnant, breast-feeding, or planning a pregnancy for the duration of the study;
- Have a history or current diagnosis of attention-deficit hyperactivity disorder (ADHD);
- Have a history of epilepsy or a seizure disorder;
- Experience disorientation, have developmental disabilities, and/or an organic mental disorder;
- fMRI-related exclusion criteria promulgated by University Research Facility in Behavioural and Systems Neuroscience (UBSN), PolyU
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.